Jon Faiz Kayyem

Dr. Kayyem has served as a member of their board of directors since April 2018. He is the founder of GenMark Diagnostics Inc. as well as a consultant to GenMark’s management and board of directors and he participates as the “Founder Observer” on the GenMark board of directors. From May 2010 until February 2018, Dr. Kayyem served in various leadership positions at GenMark including Senior Vice President of Research and Development, Chief Scientific Officer, President, and Chief Executive Officer as the company evolved from Osmetech plc.

In 2006, Dr. Kayyem founded and served as a member of the Board of Directors of privately-held Calimmune Inc. until its acquisition by CSL Behring in 2017. In 1995, he founded Clinical Micro Sensors Inc. to commercialize technical innovations he developed while serving as a Senior Research Fellow at the California Institute of Technology (Caltech). In 2000, Clinical Micro Sensors Inc. was sold to Motorola Inc. and was subsequently purchased by Osmetech plc in 2005. From June 2000 until December 2004, Dr. Kayyem served as Vice President of Life Sciences at Motorola. In October 2004, he co-founded the biotechnology fund management company, Efficacy Capital Limited, and, until September 2009, served as a managing partner. Dr. Kayyem also currently serves as a member of the board of directors of Biodesix, Inc. Dr. Kayyem received a combined B.S. and M.S. in Molecular Biophysics and Biochemistry from Yale University and a Ph.D. in Molecular Biology from Caltech.